Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Immunogenicity and Safety of Zostavax® and Shingrix® in Rheumatoid Arthritis Patients Using Abatacept

NCT03604406 is registered in ClinicalTrials.gov with Kevin Winthrop as lead sponsor.

NCT NCT03604406
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03604406 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Immunogenicity and Safety of Zostavax® and Shingrix® in Rheumatoid Arthritis Patients Using Abatacept
Lead sponsor
Kevin Winthrop
Phase
Phase 2
Overall status
Completed
Start date
May 8, 2014
Completion date
January 12, 2026
Enrollment
154 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

herpes zoster, inflammatory disease, rheumatoid arthritis